Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach

The public–private initiative Operation Warp Speed aims to deliver tens of millions of doses of an FDA-approved SARS-CoV-2 vaccine beginning at the end of 2020 and to have as many as 300 million doses of such vaccines available and deployed by mid-2021.

Saved in:

Bibliographic Details
Published in:	New England Journal of Medicine 2020-10, Vol.383 (18), p.1701
Main Authors:	Slaoui, Moncef, Hepburn, Matthew
Format:	Article
Language:	English
Subjects:	Advisory Committees Betacoronavirus Centers for Disease Control and Prevention, U.S Clinical Trials as Topic Coronavirus Infections - immunology Coronavirus Infections - prevention & control COVID-19 COVID-19 Vaccines Drug Approval Drug Development - methods Drug Development - organization & administration Drug Industry Humans Immunization - legislation & jurisprudence Pandemics - prevention & control Pneumonia, Viral - immunology Pneumonia, Viral - prevention & control RNA, Viral SARS-CoV-2 Time Factors United States United States Food and Drug Administration Viral Vaccines - immunology
Citations:	Items that cite this one
Online Access:	Request full text
Tags:	Add Tag No Tags, Be the first to tag this record!